OAZ2 and neuroblastoma: Indeed, a dramatic decrease in the expression of OAZ2 has been reported in gastric cancer [51] and neuroblastoma [52], and high levels of OAZ2 expression are positively correlated with increased survival rate and favorable clinical prognosis.